Competing interest
Haque R, Kim YS, Jang H, Kim SY, Lee H and Kim HJ report no conflict of
interest. Dr. Kim received a grant from the National Research Foundation
of Korea; received consultancy/speaker fees from Alexion, Celltrion,
Eisai, HanAll BioPharma, Merck Serono, Novartis, Sanofi Genzyme,
Teva-Handok, and Viela Bio; serves on a steering committee for
MedImmune/Viela Bio; is a co-editor for the Multiple Sclerosis Journal
and an associated editor for the Journal of Clinical Neurology.